MetaCap

United Therapeutics Statistics

NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

554.73-4.37 (-0.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

United Therapeutics by the numbers

United Therapeutics has a market capitalization of $23.63 billion based on 42.59M shares outstanding. Its trailing P/E ratio is 20.9, above the 4-company peer median of 15.0, and its forward P/E is 17.4. The stock trades 0.9% above its 50-day average and 2.8% above its 200-day average.

Average daily trading volume is 702.78K shares, or about $389.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

UTHR valuation vs. peer median

UTHR compared with the median of 8 peer companies
MetricUTHRPeer medianDifference
Market cap$23.63B$25.26B-6%
P/E (TTM)20.915.0+39%
Forward P/E17.417.5-0%
Avg. volume702.78K3.63M-81%

Peer median across 8 companies: VTRS, ROIV, ALNY, INSM, ASND, GMAB, ZTS, BBIO.

Valuation

Market cap
$23.63B
Price / sales (latest FY)
7.42
EPS (TTM)
$26.49

Price and trading

Previous close
559.10
Open
561.20
Day range
551.77 – 563.11
52-week range
455.63 – 614.23
52-week change
+16.83%
Beta
—
Volume
367.68K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
23.63B
Pe
20.94
Forward Pe
17.44
Eps
26.49
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
614.23
Week52 Low
455.63
Avg Volume
702.78K
Shares Outstanding
42.59M
Ma50
550.00
Ma200
539.85
Earnings Date
Nov 4, 2026
Pct From52w High
-9.69%
Pct From52w Low
21.75%

Related